Loading...

Katsuto Shinohara, MD

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-353-7101
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mutiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 Jul 03. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions:    Fields:    
    2. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 Jun 10; 101097JU0000000000001186. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions:    Fields:    
    3. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Differences in negative predictive value of prostate MRI based in men with suspected or known cancer. Radiol Bras. 2019 Sep-Oct; 52(5):281-286. Baghdanian AA, Kim YJ, Baghdanian AH, Nguyen HN, Shinohara K, Westphalen AC. PMID: 31656343.
      View in: PubMed   Mentions:
    6. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience. Brachytherapy. 2019 Jul - Aug; 18(4):470-476. Xu MJ, Chen KS, Chang AJ, Lazar A, Shinohara K, Cunha JAM, Hsu IC. PMID: 30954399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-13 C2 ]glucose. Magn Reson Med. 2019 08; 82(2):566-576. Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. PMID: 30924180.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy. 2018 Mar - Apr; 17(2):259-264. Wu SY, Boreta L, Wu A, Cheung JP, Cunha JAM, Shinohara K, Chang AJ. PMID: 29203149.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    15. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Nov - Dec; 16(6):1113-1118. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. PMID: 28869143.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    17. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR. PMID: 27117443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines. Adv Radiat Oncol. 2016 Jan-Mar; 1(1):51-58. Chen CP, Johnson J, Seo Y, Weinberg VK, Shinohara K, Hsu IJ, Roach M. PMID: 28799574.
      View in: PubMed   Mentions:
    24. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. PMID: 26198421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 26138041.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR. PMID: 25623742.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    29. Pre-plan parameters predict post-implant D90 = 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. PMID: 25097554.
      View in: PubMed   Mentions:
    30. Management of an increasing prostate-specific antigen level after negative prostate biopsy. Urol Clin North Am. 2014 May; 41(2):327-38. Shinohara K, Nguyen H, Masic S. PMID: 24725493.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    32. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. PMID: 24231238.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy. World J Urol. 2014 Aug; 32(4):1061-6. Li X, Fang D, Cooperberg MR, Whitson JM, Lue TF, Zhou L, Shinohara K. PMID: 24141807.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    35. The role of metabolic imaging in radiation therapy of prostate cancer. NMR Biomed. 2014 Jan; 27(1):100-11. Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 23940096.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. PMID: 23474112.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    37. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):370-7. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. PMID: 22672747.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    39. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    40. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012 Feb; 109 Suppl 1:22-9. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. PMID: 22239226.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    41. Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):100-5. Wu AK, Reese AC, Cooperberg MR, Sadetsky N, Shinohara K. PMID: 22042252.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 21944082.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    44. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 2011 Jul; 24(6):691-9. Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 21793074.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    45. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J Nucl Med. 2011 Jul; 52(7):1068-72. Seo Y, Aparici CM, Chen CP, Hsu C, Kased N, Schreck C, Costouros N, Hawkins R, Shinohara K, Roach Iii M. PMID: 21680690.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    46. [Cryosurgery]. Nihon Rinsho. 2011 Jun; 69 Suppl 5:572-5. Shinohara K. PMID: 22208046.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. PMID: 21632511.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    48. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. PMID: 20804478.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    49. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. PMID: 21419438.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    50. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):228-34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. PMID: 21183287.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    51. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):222-7. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. PMID: 21163586.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. PMID: 21115873.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    53. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    54. Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol. 2010 Aug; 19(4):189-202. Cunha JA, Hsu IC, Pouliot J, Roach Iii M, Shinohara K, Kurhanewicz J, Reed G, Stoianovici D. PMID: 20642386.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    55. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    56. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):751-8. Hsu IC, Bae K, Shinohara K, Pouliot J, Purdy J, Ibbott G, Speight J, Vigneault E, Ivker R, Sandler H. PMID: 20207506.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    57. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):36-42. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. PMID: 19409729.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    59. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2010 Jul; 106(2):194-8. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, Hernandez M, Bossier J, Kassouf W, Pisters LL. PMID: 19922545.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    60. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010 May; 105(9):1237-41. Eisenberg ML, Cowan JE, Carroll PR, Shinohara K. PMID: 19888980.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Pain: easing the pain: local anesthesia for prostate biopsy. Nat Rev Urol. 2009 Jul; 6(7):360-1. Shinohara K. PMID: 19578353.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1061-5. Potters L, Roach M, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW. PMID: 19540064.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review. Int J Urol. 2009 Jun; 16(6):558-60. Ikeda T, Shinohara K. PMID: 19456987.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. PMID: 19428310.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol. 2011 Mar-Apr; 29(2):171-6. Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. PMID: 19362864.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. PMID: 19245439.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    67. Re: Residual urinary volume and urinary tract infection--when are they linked?: J. C. Truzzi, F. M. Almeida, E. C. Nunes and M. V. Sadi, J Urol 2008; 180: 182-185. J Urol. 2009 Feb; 181(2):919; author reply 919-20. Breyer BN, Shinohara K. PMID: 19110278.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008 Nov; 180(5):1993-2004. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, Katz A, Pisters L, Rukstalis D, Shinohara K, Thrasher JB. PMID: 18817934.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    69. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med. 2008 Sep; 60(3):510-6. Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. PMID: 18727052.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    70. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008 Dec; 72(6):1315-8. Eisenberg ML, Shinohara K. PMID: 18597824.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    71. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):341-6. Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. PMID: 18597953.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    72. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. PMID: 18581409.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    73. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. PMID: 18559852.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    74. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. PMID: 18433013.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCTClinical Trials
    75. Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer. J Ultrasound Med. 2008 Jun; 27(6):895-905. Shen F, Shinohara K, Kumar D, Khemka A, Simoneau AR, Werahera PN, Li L, Guo Y, Narayanan R, Wei L, Barqawi A, Crawford ED, Davatzikos C, Suri JS. PMID: 18499849.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    76. Ejaculatory duct manometry in normal men and in patients with ejaculatory duct obstruction. J Urol. 2008 Jul; 180(1):255-60; discussion 260. Eisenberg ML, Walsh TJ, Garcia MM, Shinohara K, Turek PJ. PMID: 18499178.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. PMID: 18430877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. Technique for implantation of fiducial markers in the prostate. Urology. 2008 Feb; 71(2):196-200. Shinohara K, Roach M. PMID: 18308082.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    79. Comparison of prostate and transition zone volume measured by the ellipsoid and planimetric methods with transrectal ultrasonography before seed implantation of prostate cancer. Int J Urol. 2008 Feb; 15(2):190-1. Ikeda T, Shinohara K. PMID: 18269465.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Cryotherapy. Int J Clin Oncol. 2007 Dec; 12(6):416-26. Shinohara K. PMID: 18071860.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1199-206. Litzenberg DW, Willoughby TR, Balter JM, Sandler HM, Wei J, Kupelian PA, Cunningham AA, Bock A, Aubin M, Roach M, Shinohara K, Pouliot J. PMID: 17513060.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    82. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):610-9. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. PMID: 17236978.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    83. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. PMID: 17197119.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    84. Improving cancer detection by prostate biopsy: the role of core number and site. Nat Clin Pract Urol. 2006 Oct; 3(10):526-7. Shinohara K. PMID: 17031375.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 16685733.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    86. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Jun 01; 65(2):528-34. Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach M, Skrumeda LL, Balter JM, Litzenberg DW, Hadley SW, Wei JT, Sandler HM. PMID: 16690435.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    87. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):65-72. Pickett B, Kurhanewicz J, Pouliot J, Weinberg V, Shinohara K, Coakley F, Roach M. PMID: 16517094.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 09; 354(6):557-66. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. PMID: 16467543.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCTClinical Trials
    89. Local anesthesia during 10 core biopsy of the prostate: comparison of 2 methods. J Urol. 2005 Mar; 173(3):742-5. Mutaguchi K, Shinohara K, Matsubara A, Yasumoto H, Mita K, Usui T. PMID: 15711260.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    90. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. PMID: 16182220.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    91. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol. 2004 Dec; 172(6 Pt 1):2197-202. Master VA, Shinohara K, Carroll PR. PMID: 15538231.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    92. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1047-55. Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. PMID: 15519774.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    93. Thermal ablation of prostate diseases: advantages and limitations. Int J Hyperthermia. 2004 Nov; 20(7):679-97. Shinohara K. PMID: 15675665.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    94. Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):470-5. Liu YM, Ling S, Langen KM, Shinohara K, Weinberg V, Pouliot J, Roach M. PMID: 15380581.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 2004 Nov; 233(2):441-8. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 15375223.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    96. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):665-73. Pickett B, Ten Haken RK, Kurhanewicz J, Qayyum A, Shinohara K, Fein B, Roach M. PMID: 15183469.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    97. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):6-10. Millender LE, Aubin M, Pouliot J, Shinohara K, Roach M. PMID: 15093893.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    98. A prospective comparison of 3 diagnostic methods to evaluate ejaculatory duct obstruction. J Urol. 2004 Jan; 171(1):232-5; discussion 235-6. Purohit RS, Wu DS, Shinohara K, Turek PJ. PMID: 14665883.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    99. Prostate cancer: cryotherapy. Urol Clin North Am. 2003 Nov; 30(4):725-36, viii. Shinohara K. PMID: 14680310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    100. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):635-44. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. PMID: 14529767.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    101. The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol. 2003 Sep-Oct; 21(5):361-5. Meng MV, Franks JH, Presti JC, Shinohara K. PMID: 14670545.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Choosing imaging modality in 2003. J Urol. 2003 Sep; 170(3):803. Shinohara K. PMID: 12913702.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):862-6. Pouliot J, Aubin M, Langen KM, Liu YM, Pickett B, Shinohara K, Roach M. PMID: 12788196.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    104. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003 May; 30(2):279-93. Purohit RS, Shinohara K, Meng MV, Carroll PR. PMID: 12735504.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    105. Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urol Oncol. 2003 Mar-Apr; 21(2):145-51. Meng MV, Shinohara K, Grossfeld GD. PMID: 12856644.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    106. Transperineal prostate biopsy after abdominoperineal resection. J Urol. 2003 Jan; 169(1):141-4. Shinohara K, Gulati M, Koppie T, Terris MK. PMID: 12478122.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    107. Rectal wall recurrence of prostatic adenocarcinoma. J Urol. 2002 Nov; 168(5):2120. Koppie TM, Grady BP, Shinohara K. PMID: 12394725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer. J Urol. 2002 Jul; 168(1):105-9. Elliott SP, Shinohara K, Logan SL, Carroll PR. PMID: 12050501.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001 May; 165(5):1409-14. Park S, Shinohara K, Grossfeld GD, Carroll PR. PMID: 11342887.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    110. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1461-7. Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu IC, Roach M. PMID: 11121649.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    111. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol. 2000 Nov 01; 18(21):3595-603. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM. PMID: 11054432.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    112. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology. 2000 Oct 01; 56(4):622-6. Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR. PMID: 11018618.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    113. [Cryosurgery]. Nihon Rinsho. 2000 Jul; 58 Suppl:306-8. Shinohara K. PMID: 11022736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):851-8. Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, Phillips T. PMID: 10705005.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000 Jan; 163(1):163-6; discussion 166-7. Presti JC, Chang JJ, Bhargava V, Shinohara K. PMID: 10604337.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    116. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology. 1999 Oct; 54(4):689-93. Tigrani VS, Bhargava V, Shinohara K, Presti JC. PMID: 10510929.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    117. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999 Aug; 162(2):427-32. Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll PR. PMID: 10411051.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    118. Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology. 1998 Dec; 52(6):1079-84. Presti JC, Shinohara K, Bacchetti P, Tigrani V, Bhargava V. PMID: 9836558.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    119. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 1998 Dec; 160(6 Pt 1):2111-4. Chang JJ, Shinohara K, Bhargava V, Presti JC. PMID: 9817334.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    120. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 1998 Nov; 160(5):1748-53. Rogers R, Grossfeld GD, Roach M, Shinohara K, Presti JC, Carroll PR. PMID: 9783945.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    121. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology. 1998 Jul; 52(1):89-93. Chang JJ, Shinohara K, Hovey RM, Montgomery C, Presti JC. PMID: 9671876.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    122. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997 Dec; 158(6):2206-9; discussion 2209-10. Shinohara K, Rhee B, Presti JC, Carroll PR. PMID: 9366345.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol. 1997 Dec; 80(6):918-22. Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll PR. PMID: 9439410.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):244-9. Connolly JA, Shinohara K, Carroll PR. PMID: 9421452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 1997 Sep; 50(3):373-8. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC. PMID: 9301700.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    126. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Urol. 1997 Aug; 158(2):515-8. Connolly JA, Presti JC, Cher ML, Chew K, Shinohara K, Carroll PR. PMID: 9224336.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am. 1997 May; 24(2):415-20. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 9126239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations. J Urol. 1997 Mar; 157(3):907-11; discussion 911-2. Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K. PMID: 9072597.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    129. Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy. Urol Oncol. 1996 Nov-Dec; 2(6):177-83. Presti JC, Hricak H, Shinohara K, Carroll PR. PMID: 21224166.
      View in: PubMed   Mentions: 1     Fields:    
    130. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996 Nov; 23(4):623-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8948416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    131. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J Urol. 1996 Nov; 156(5):1685-90. Presti JC, Hovey R, Carroll PR, Shinohara K. PMID: 8863571.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    132. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 1996 Oct; 48(4):594-9. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. PMID: 8886066.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    133. Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection. Urol Oncol. 1996 Sep-Oct; 2(5):136-8. Seltzer MA, Shinohara K, Bhargava V, Carroll PR, Presti JC. PMID: 21224157.
      View in: PubMed   Mentions: 1     Fields:    
    134. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996 Aug; 200(2):489-96. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR. PMID: 8685346.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    135. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996 Jul; 156(1):115-20; discussion 120-1. Shinohara K, Connolly JA, Presti JC, Carroll PR. PMID: 8648771.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    136. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound. 1996 May; 24(4):169-74. Tewari A, Indudhara R, Shinohara K, Schalow E, Woods M, Lee R, Anderson C, Narayan P. PMID: 8727414.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    137. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 1996 Mar; 198(3):807-11. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR. PMID: 8628875.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    138. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology. 1996 Feb; 47(2):225-31. Connolly JA, Shinohara K, Presti JC, Carroll PR. PMID: 8607239.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    139. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996 Feb; 155(2):607-9. Nash PA, Bruce JE, Indudhara R, Shinohara K. PMID: 8558671.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    140. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol. 1996 Jan; 166(1):103-8. Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. PMID: 8571856.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    141. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995 Sep; 76(3):355-9. Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll PR. PMID: 7551846.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    142. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Br J Urol. 1995 Jun; 75(6):771-7. Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. PMID: 7542137.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    143. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol. 1994 Jul; 152(1):120-3. Shinohara K, Wolf JS, Narayan P, Carroll PR. PMID: 7515447.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    144. Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology. 1994 Jun; 43(6):813-20. Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A. PMID: 7515205.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. Role of penile vascular injury in erectile dysfunction after radical prostatectomy. Br J Urol. 1994 Jan; 73(1):75-82. Aboseif S, Shinohara K, Breza J, Benard F, Narayan P. PMID: 8298902.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer. Urol Int. 1994; 53(4):191-5. Vapnek JM, Hricak H, Shinohara K, Popovich M, Carroll P. PMID: 7855937.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    147. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology. 1993 Dec; 42(6):680-8. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR. PMID: 8256401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    148. Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer. Urology. 1993 Aug; 42(2):131-7. Wolf JS, Shinohara K, Carroll PR, Narayan P. PMID: 7690168.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    149. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol. 1993 May; 149(5):1024-8. Foster LS, Jajodia P, Fournier G, Shinohara K, Carroll P, Narayan P. PMID: 7683341.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    150. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen. Br J Urol. 1992 Nov; 70(5):534-41. Wolf JS, Shinohara K, Narayan P. PMID: 1281724.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Katsuto's Networks
    Concepts (312)
    Derived automatically from this person's publications.
    _
    Co-Authors (53)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _